News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Shattuck Labs
NEWS
JOBS
IN THE PRESS
NEWS
Layoffs
Shattuck Labs to Lay Off 40% of Workforce
As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.
October 1, 2024
·
2 min read
·
Angela Gabriel
Deals
4 Biotech IPOs this Week: Kronos, Shattuck, Spruce and Aziyo
It’s been a fairly busy week for biotech initial public offerings (IPOs) with four announcing their list pricing. Here’s a look.
October 9, 2020
·
4 min read
·
Mark Terry
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the ASH 2023 Annual Meeting
November 2, 2023
·
8 min read
Business
Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights
August 10, 2023
·
12 min read
Drug Development
Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
May 25, 2023
·
7 min read
Business
Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights
May 9, 2023
·
12 min read
Bio NC
Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting
March 16, 2023
·
3 min read
Bio NC
Shattuck Labs Announces Participation in Upcoming March 2023 Conferences
March 1, 2023
·
2 min read
Business
Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates
February 23, 2023
·
17 min read
Business
Shattuck Labs to Report Fourth-Quarter and Full-Year 2022 Financial Results on February 23, 2023
February 16, 2023
·
2 min read
Bio NC
Shattuck Labs Announces Participation in Upcoming SVB Securities Global Biopharma Conference
February 9, 2023
·
1 min read
Bio NC
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2023
January 9, 2023
·
7 min read
